A. Geragotellis, Abedalaziz O Surkhi, Matti Jubouri, Ayah S Alsmadi, Yazan El-Dayeh, Fatima Kayali, Idhrees Mohammed, M. Bashir
{"title":"Endovascular reintervention after frozen elephant trunk: where is the evidence?","authors":"A. Geragotellis, Abedalaziz O Surkhi, Matti Jubouri, Ayah S Alsmadi, Yazan El-Dayeh, Fatima Kayali, Idhrees Mohammed, M. Bashir","doi":"10.23736/S0021-9509.22.12393-1","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nThe introduction of the single-step hybrid frozen elephant trunk (FET) procedure for total arch replacement has revolutionised the field of aortovascular surgery. FET has proven to achieve excellent results in the repair of complex thoracic aorta pathologies. However, there remains a risk of reintervention post-FET for a variety of causes. This secondary intervention can either be performed endovascular, with thoracic endovascular aortic repair (TEVAR), or via open surgery. Multiple FET hybrid prosthesis are commercially available, each requiring different rates of endovascular reintervention. The current review will focus on providing an overview of the reintervention rates for main causes in relation to the FET grafts on the market. In addition, strategies to prevent reintervention will be highlighted.\n\n\nEVIDENCE ACQUISITION\nA comprehensive literature search was conducted on multiple electronic databases including PubMed, Ovid, Scopus and Embase to highlight the evidence in the literature on endovascular reintervention after FET.\n\n\nEVIDENCE SYNTHESIS\nThe main causes for secondary intervention are distal stent graft-induced new entry (dSINE), endoleak and negative aortic remodelling, and to a much lesser extent, graft kinking and aorto-oesophageal fistulae. In addition, it is clear that the Thoraflex Hybrid is the superior FET device, showing excellent reintervention rates for all the above causes. Interestingly, the choice of FET device as well as its size and length can help prevent the need for reintervention.\n\n\nCONCLUSIONS\nThe FET procedure is indeed associated with excellent clinical outcomes, however, the need for reintervention may still arise. Importantly, the Thoraflex Hybrid prosthesis has shown excellent results when it comes to endovascular reintervention. Finally, several strategies exist that can prevent reintervention.","PeriodicalId":101333,"journal":{"name":"The Journal of cardiovascular surgery","volume":"66 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of cardiovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0021-9509.22.12393-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
INTRODUCTION
The introduction of the single-step hybrid frozen elephant trunk (FET) procedure for total arch replacement has revolutionised the field of aortovascular surgery. FET has proven to achieve excellent results in the repair of complex thoracic aorta pathologies. However, there remains a risk of reintervention post-FET for a variety of causes. This secondary intervention can either be performed endovascular, with thoracic endovascular aortic repair (TEVAR), or via open surgery. Multiple FET hybrid prosthesis are commercially available, each requiring different rates of endovascular reintervention. The current review will focus on providing an overview of the reintervention rates for main causes in relation to the FET grafts on the market. In addition, strategies to prevent reintervention will be highlighted.
EVIDENCE ACQUISITION
A comprehensive literature search was conducted on multiple electronic databases including PubMed, Ovid, Scopus and Embase to highlight the evidence in the literature on endovascular reintervention after FET.
EVIDENCE SYNTHESIS
The main causes for secondary intervention are distal stent graft-induced new entry (dSINE), endoleak and negative aortic remodelling, and to a much lesser extent, graft kinking and aorto-oesophageal fistulae. In addition, it is clear that the Thoraflex Hybrid is the superior FET device, showing excellent reintervention rates for all the above causes. Interestingly, the choice of FET device as well as its size and length can help prevent the need for reintervention.
CONCLUSIONS
The FET procedure is indeed associated with excellent clinical outcomes, however, the need for reintervention may still arise. Importantly, the Thoraflex Hybrid prosthesis has shown excellent results when it comes to endovascular reintervention. Finally, several strategies exist that can prevent reintervention.